Calcium Citrate Maleate, Zinc, Magnesium, Cholecalciferol & Vitamin K2-7 Tablets

₹ 78/Stripe

Strength1000 mg
Calcium Strength250 mg
Vitamin D3 Strength200 IU
FormTablet
Pack TypeStrips
UsageGeneral supplement, Calcium deficiency
Pack Size10*10 Tablets
ManufacturerMits healthcare
Prescription/Non-PrescriptionPrescription
Country of OriginMade in India
AvailabilityIn Stock
  1. Calcium Citrate Malate (CCM): This form of calcium is more easily absorbed by the body than other types. It supports bone health and teeth strength1.

  2. Zinc: An essential mineral that plays a role in immune function, wound healing, and overall health.

  3. Magnesium: Crucial for bone health, muscle function, and energy production.

  4. Cholecalciferol (Vitamin D3): Helps the body absorb calcium and maintain bone density. It's also important for immune function and overall well-being.

  5. Vitamin K2-7: Supports bone health by directing calcium to bones and preventing it from accumulating in soft tissues. It works synergistically with vitamin D31.

These tablets are designed to provide a convenient way to supplement these nutrients. Remember to consult with a healthcare professional before starting any new supplement.

Exports To: United States Of America | Nepal | Sri Lanka | Egypt | Saudi Arabia

Shipping Information

PriceExcluding all taxes
Ships fromMumbai
ShippingAs per delivery location

Product Video

Product Image

Calcium Citrate Maleate, Zinc, Magnesium, Cholecalciferol & Vitamin K2-7 Tablets-1Calcium Citrate Maleate, Zinc, Magnesium, Cholecalciferol & Vitamin K2-7 Tablets-2Calcium Citrate Maleate, Zinc, Magnesium, Cholecalciferol & Vitamin K2-7 Tablets-3Calcium Citrate Maleate, Zinc, Magnesium, Cholecalciferol & Vitamin K2-7 Tablets-4Calcium Citrate Maleate, Zinc, Magnesium, Cholecalciferol & Vitamin K2-7 Tablets-5Calcium Citrate Maleate, Zinc, Magnesium, Cholecalciferol & Vitamin K2-7 Tablets-6

Interested in this product?Get Latest Price from the seller

About the Company

GST Registration Date
14-11-2018
Legal Status of Firm
Limited Company
Nature of Business
Trader - Wholesaler/Distributor
Number of Employees
11 To 25 People
Annual Turnover
25 - 100 Cr
IndiaMART Member Since
Jan 2012
GST
27AAKCP0253H1ZG
Import Export Code (IEC)
AAKCP*****
Exports to
United States Of America | Nepal | Sri Lanka | Egypt | Saudi Arabia

Over The Years, M/s.Prakash Bio Pharma Has Been Able To Carve A Niche For Itself And Is Looking Forward To Expand The Volumes. We Would Like To Introduce Ourselves As A Super Speciality Distributor Dealing In The Field Of Oncology, Haematology, Nephrology, Neurology, Cardiology, Gynaecology Etc. We Have Chosen Marketing & Distribution Of World Class Health Care Products As Our Area Of Contribution To The Cause. We Have Dedicated Ourselves To Making Significant And Admirable Contribution By Being The Company Of Total Integrity. Our Strength Lies In Our Educated, Experienced, Professional And Technical Staff That Is Always Ready To Render Their Services For The Betterment Of The Social Community With A Prime Objective Of Service To The Mankind Besides Our Profit Margin.
M/s.Prakash Bio Pharma Knows That OurCustomer's Satisfaction Is The Key To Our Success; Past, Present &Future. M/s. Prakash Bio Pharma Is A Leading Distribution Network In Mumbai Since Year 2000, We Have Distribution Of Multinational Companies Such As Novartis, Mylan, Roche And Various Indian Companies In Specialty. We Have A Large Network In Mumbai & Around To Cater Demand For More Than 2500 Retail Outlets And Various Hospitals.
Mr.Deepak Shete, Proprietor, Has An Extensive Experience In The Pharmaceutical Distribution. He Is An Entrepreneur With Immense Knowledge In This Industry Contributing To The Company’s Success And Growth. To Manage Our Operation, We Have A Large Set Up Of Work Force 20 Plus Including The Pharmacist.

We Are Financially Stable And Efficient Organization Which Is Flexible In Nature As Per Need Of Our Principals And Ready To Invest Any Amount Proportionate To The Business. Currently M/s. Prakash Bio Pharma Is A 25 Cr Organization And Growing. (Targeting 30 Cr In 2017 – 2018).